Ready, Set, Go: The EGF Receptor at the Pancreatic Cancer Starting Line
- 1 September 2012
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 22 (3) , 281-282
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- EGF Receptor Is Required for KRAS-Induced Pancreatic TumorigenesisCancer Cell, 2012
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Pancreatic ductal cells in development, regeneration, and neoplasiaJournal of Clinical Investigation, 2011
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyNature Medicine, 2011
- Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic CancerCancer Research, 2008
- Signaling on the endocytic pathwayCurrent Opinion in Cell Biology, 2007
- Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupJournal of Clinical Oncology, 2007
- Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediatesDevelopment, 2005
- Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesisCancer Cell, 2003
- Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cellsGastroenterology, 2002